<DOC>
	<DOCNO>NCT01439841</DOCNO>
	<brief_summary>HIV progression closely associate chronic immune activation drive leakage bacterial product damage gut , investigator large immunological organ . Notably , degree immune activation suggest good predictor disease progression plasma viral load , marker immune activation gut damage identify therapeutic target per se . The major damage HIV immune system initial massacre gut mucosal CD4+ Th17 cell . Interestingly , normal gut flora show induce maturation Th17 cell small intestine mucosa . Preliminary report show gut flora alter HIV-1 infection compare control . In project , investigator characterize microbial composition gut flora chronic HIV infection ultradeep sequencing . Gut flora composition relate clinical data well quantitative data circulate microbial product activation marker . Second , randomize clinical trial ( RCT ) effect probiotic lactobacillus HIV pathogenesis progression test . This Gram-positive strain clinically test able colonize gut .</brief_summary>
	<brief_title>The Effect Probiotics HIV-1 Infection</brief_title>
	<detailed_description>Objectives : To explore ( ) safety tolerability , ( ii ) efficacy probiotic HIV-associated microbial translocation , systemic immune activation , disease progression composition gut microbiota chronic HIV-1 infection . Methodology/Study design : Approximately 50 patient without current indication antiretroviral treatment ( ART ) 50 patient receive ART without normalised CD4 count include . A control clinical trial carry within stratum randomise 2:1:1 fashion double blind intervention placebo arm well open , untreated control arm , respectively .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>For patient without ART : Confirmed diagnosis HIV infection &gt; 6 month CD4+ T cell count &lt; 900 For patient stable , effective ART : HIV RNA &lt; 50 copies/ml &gt; 6 month CD4+ T cell count &gt; 500 Signed inform consent . Severe illness require hospitalization Systemic antibiotic probiotic last two month Current immune modulate therapy Infectious diarrhea Inflammatory bowel disease Acute primary HIV infection Patients immigrate Africa , Asia LatinAmerica within last 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>HIV</keyword>
	<keyword>microbial translocation</keyword>
	<keyword>immune activation</keyword>
	<keyword>probiotic</keyword>
</DOC>